Correction: Annals of Intensive Care (2024) 14:41 https://doi.org/10.1186/s13613-024-01276-4
In Table 2 of this article [1], the data in the [Primary endpoint reached, n (%)] headed Sevoflurane, should be listed as 11 (39) not 11 (16).
Primary Endpoint Reached, it reads, that 11 patients in the sevoflurane and 13 in the propofol group reached the primary endpoint. This is correct, but the percentages are incorrect, they should be 39 and 41%, respectively.
Table 2 Primary and secondary outcomes (uncorrected)
Variable | Sevoflurane | Control | p-value |
|---|---|---|---|
Primary outcome | n = 28 | n = 32 | |
Primary endpoint reached, n (%) | 11 (16) | 13 (41) | 0.916 |
Death, n (%) | 5 (16) | 5 (18) | 0.817 |
Survivors | n = 23 | n = 27 |
2: Primary and secondary outcomes (corrected)
Variable | Sevoflurane | Control | p-value |
|---|---|---|---|
Primary outcome | n = 28 | n = 32 | |
Primary endpoint reached, n (%) | 11 (39) | 13 (41) | 0.916 |
Death, n (%) | 5 (16) | 5 (18) | 0.817 |
Survivors | n = 23 | n = 27 |
The original article has been corrected.
Reference
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger BD, Neff TA, Schläpfer M. Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care. 2024;14:41. https://doi.org/10.1186/s13613-024-01276-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Beck-Schimmer, B., Schadde, E., Pietsch, U. et al. Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial. Ann. Intensive Care 14, 90 (2024). https://doi.org/10.1186/s13613-024-01322-1
Published:
DOI: https://doi.org/10.1186/s13613-024-01322-1